CBCI is a Foundation for the Accreditation of Cellular Therapies (FACT) accredited center for stem cell transplantation. Dr. Richard Nash and his team have over 20 years of experience with Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for autoimmune diseases.

We participated in a previous clinical trial in which we transplanted patients with autoimmune neurological disorders which has closed. We are now developing the following clinical trials:

Stiff Person Syndrome / Stiff Person Spectrum Disorder (SPS / SPSD)

  • Autologous stem cell transplant study for SPS / SPSD
  • Allogeneic stem cell transplant study for SPS / SPSD patients who have failed autologous treatment

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Autologous stem cell transplant study for CIDP

Myasthenia Gravis (MG)

We are also developing clinical trials for the following autoimmune conditions:

  • Primary Central Nervous System (CNS) vasculitis
  • Autoimmune peripheral neuropathy (anti-Hu [Anna-1], anti-GM1 [GD1b], anti-MAG, anti-ganglioside, anti-sulfatide)
  • Autoimmune cerebellar degeneration
  • Rasmussen’s Encephalitis
  • Gait Ataxia with Late age Onset Polyneuropathy (GALOP)
  • Lambert-Eaton myasthenic syndrome
  • Human T-cell lymphotropic virus (HTLV)-1-associated myelopathy (HAM) / tropical spastic paraparesis (TSP)
  • Opsoclonus/myoclonus (anti-Ri)
  • Neuromyelitis optica
  • Other central or peripheral nervous system autoimmune diseases as approved by study neurologists

If you are interested in being screened for any of these studies, please contact:

Email Cat Booher
Phone number: (303) 577-6480